Adenoids and Adenoiditis: Comprehensive Overview
Anatomy and Function
Adenoids are secondary lymphoid organs located in the nasopharynx that serve as critical components of upper respiratory tract immunity. They function as both inductive organs of mucosal immunity and effector sites for immune responses, expressing HLA-DR molecules through specialized reticular epithelium 1. The tissue contains predominantly IgG3 and IgA1 antibodies and demonstrates age-related morphologic changes, with cellular immune responses predominating in young children and humoral responses increasing with age 2, 1.
The adenoids act as a nasopharyngeal reservoir for respiratory pathogens, which explains their role in middle ear disease through bacterial access via the Eustachian tube 3. This reservoir function is independent of adenoid size 3.
Clinical Features
Adenoid Hypertrophy
Adenoidal hypertrophy becomes pathologic when it causes mechanical obstruction and/or chronic inflammation 4. Key clinical manifestations include:
- Obstructive symptoms: Mouth breathing, nasal obstruction, snoring, sleep apnea, hyponasal speech 2
- Adenoid facies (long face syndrome): Permanently open mouth with visible tongue tip 4
- Associated conditions: Rhinosinusitis, recurrent otitis media, otitis media with effusion (OME) 2
- Eustachian tube dysfunction: Leading to conductive hearing loss, cholesteatoma, recurrent acute otitis media 4
Adenoiditis
Chronic adenoiditis presents with:
- Persistent postnasal discharge
- Nasal obstruction unresponsive to medical management
- Recurrent upper respiratory infections
- Thick white film covering hypertrophic adenoids (may indicate viral infection including herpes virus) 5
Allergic adenoiditis represents a distinct entity where adenoid tissue exhibits numerous IgE-positive mast cells, though the connection between allergies and adenoidal disease remains incompletely understood 6.
Diagnosis
Nasal endoscopy is the key diagnostic tool for detecting both adenoid hypertrophy and adenoiditis 6. Direct visualization of the postnasal space using a transoral mirror or 120-degree endoscope prior to surgery aids diagnosis and can identify bacterial biofilms that may explain concomitant recurrent otitis media and chronic sinusitis 6, 5.
Clinical examination should assess:
- Degree of nasopharyngeal obstruction
- Presence of adenoid facies
- Associated middle ear disease (tympanometry, hearing assessment)
- Sleep-disordered breathing symptoms
- Developmental risk factors
Active mucopurulent discharge should raise concern for bacterial, fungal, or viral infection 5.
Treatment
Conservative Management
Intranasal corticosteroids should be trialed before surgical intervention for adenoidal hypertrophy 7. Medical treatments including decongestants and antihistamines are either ineffective or may cause adverse effects for OME 8.
For viral adenoiditis (including herpes virus), oral antiviral medication can be successful, with follow-up endoscopy confirming resolution 5.
Surgical Indications
Adenoidectomy is indicated when distinct symptoms exist: chronic adenoiditis, nasal obstruction unresponsive to medical management, or as adjuvant therapy in specific middle ear disease scenarios 9.
For Otitis Media with Effusion:
- Initial surgery: Tympanostomy tubes are preferred; adenoidectomy should NOT be performed unless distinct indications exist (nasal obstruction, chronic adenoiditis) 9
- Repeat surgery: Adenoidectomy is recommended when children need repeat surgery after tube extrusion, conferring 50% reduction in future operations 9
- Age considerations: Benefit apparent at age 2 years, greatest for children ≥4 years old, independent of adenoid size 9
For Sleep-Disordered Breathing:
Adenotonsillectomy is the first-line treatment for children with obstructive sleep apnea syndrome (OSAS) and adenotonsillar hypertrophy 10. Adenoidectomy or tonsillectomy alone may be insufficient due to residual lymphoid tissue 10.
Age-Specific Guidance:
- Children <4 years: Adenoidectomy NOT recommended for middle ear disease without direct adenoid symptoms (infection/obstruction) 3
- Children ≥4 years: Adjuvant adenoidectomy with tympanostomy tubes reduces MEE prevalence, achieves comparable hearing outcomes, and doubles benefit duration from 12 to 24 months 3
Surgical Technique
Conventional curettage remains the established standard treatment 4. The procedure is typically performed on an outpatient basis 4. Histologic evaluation is indicated for clinical evidence of mucopolysaccharidoses 4.
Surgical Risks and Complications
Important risks to discuss with caregivers include:
- Hemorrhage: 0.2-0.5% incidence 9
- Velopharyngeal insufficiency: 2% transient, with risk of persistent insufficiency 9, 3
- Grisel's syndrome (atlantoaxial subluxation) 3
- Nasopharyngeal stenosis 9, 3
- Anesthesia-related: Changes from mask to intubation technique, with risks of difficult airway, postoperative nausea/vomiting, pain control issues 3
- Anesthesia mortality: Approximately 1:50,000 for ambulatory surgery 9
High-Risk Populations for Postoperative Complications:
- Age <3 years
- Severe OSAS on polysomnography
- Cardiac complications of OSAS
- Failure to thrive
- Obesity
- Craniofacial anomalies
- Neuromuscular disorders 10
Contraindications
Absolute contraindications to adenoidectomy:
Postoperative Management
Otorhinolaryngologic inspection of the nasopharynx for secondary bleeding should be performed before discharge, with anesthesiologic clearance obtained 4. Recurrence of adenoids is possible despite correct adenoidectomy 4.
Key Clinical Pitfalls
Do not perform adenoidectomy for middle ear disease in children <4 years without direct adenoid symptoms - the added surgical and anesthetic risks outweigh limited benefits 3
Adenoid size does not predict benefit - the therapeutic effect relates to bacterial reservoir removal, not tissue bulk 3
Risk factors for complications include parental smoking, large daycare attendance, pacifier use, and <3 months breastfeeding 3
Active mucopurulent discharge warrants investigation for atypical infections including viral pathogens before proceeding to surgery 5